Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2014, Article ID 490275, 6 pages
http://dx.doi.org/10.1155/2014/490275
Review Article

Necroptosis: Molecular Signalling and Translational Implications

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Section of Histology and Medical Embryology, Sapienza University of Rome, Via Scarpa 14, 00161 Rome, Italy

Received 10 October 2013; Revised 11 December 2013; Accepted 16 December 2013; Published 23 January 2014

Academic Editor: Alessio Paone

Copyright © 2014 Claudia Giampietri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Vercammen, R. Beyaert, G. Denecker et al., “Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor,” The Journal of Experimental Medicine, vol. 187, no. 9, pp. 1477–1485, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Holler, R. Zaru, O. Micheau et al., “Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule,” Nature Immunology, vol. 1, no. 6, pp. 489–495, 2000. View at Google Scholar · View at Scopus
  3. A. Kawahara, Y. Ohsawa, H. Matsumura, Y. Uchiyama, and S. Nagata, “Caspase-independent cell killing by Fas-associated protein with death domain,” Journal of Cell Biology, vol. 143, no. 5, pp. 1353–1360, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. van Raam and G. S. Salvesen, “Proliferative versus apoptotic functions of caspase-8: Hetero or homo: the caspase-8 dimer controls cell fate,” Biochimica et Biophysica Acta, vol. 1824, no. 1, pp. 113–122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Festjens, T. Vanden Berghe, and P. Vandenabeele, “Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response,” Biochimica et Biophysica Acta, vol. 1757, no. 9-10, pp. 1371–1387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Wu, P. Liu, and J. Li, “Necroptosis: an emerging form of programmed cell death,” Critical Reviews in Oncology/Hematology, vol. 82, pp. 249–258, 2012. View at Google Scholar
  7. F. K.-M. Chan, J. Shisler, J. G. Bixby et al., “A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses,” The Journal of Biological Chemistry, vol. 278, no. 51, pp. 51613–51621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Matsumura, Y. Shimizu, Y. Ohsawa, A. Kawahara, Y. Uchiyama, and S. Nagata, “Necrotic death pathway in Fas receptor signaling,” Journal of Cell Biology, vol. 151, no. 6, pp. 1247–1256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Vercammen, G. Brouckaert, G. Denecker et al., “Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways,” The Journal of Experimental Medicine, vol. 188, no. 5, pp. 919–930, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Fulda, “The mechanism of necroptosis in normal and cancer cells,” Cancer Biology & Therapy, vol. 14, no. 11, pp. 999–1004, 2013. View at Google Scholar
  11. D. E. Christofferson and J. Yuan, “Necroptosis as an alternative form of programmed cell death,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 263–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Moujalled, W. D. Cook, T. Okamoto et al., “TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1,” Cell Death & Disease, vol. 4, article e465, 2013. View at Google Scholar
  13. Y. S. Cho, S. Challa, D. Moquin et al., “Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation,” Cell, vol. 137, no. 6, pp. 1112–1123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Vanlangenakker, T. Vanden Berghe, P. Bogaert et al., “cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production,” Cell Death and Differentiation, vol. 18, no. 4, pp. 656–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D.-W. Zhang, J. Shao, J. Lin et al., “RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis,” Science, vol. 325, no. 5938, pp. 332–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. He, L. Wang, L. Miao et al., “Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha,” Cell, vol. 137, no. 6, pp. 1100–1111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Feng, Y. Yang, Y. Mei et al., “Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain,” Cellular Signalling, vol. 19, no. 10, pp. 2056–2067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Lin, A. Devin, A. Cook et al., “The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IκB kinase and c-Jun N-terminal kinase,” Molecular and Cellular Biology, vol. 20, no. 18, pp. 6638–6645, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Martinon, N. Holler, C. Richard, and J. Tschopp, “Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP,” FEBS Letters, vol. 468, no. 2-3, pp. 134–136, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Narayan, I. H. Lee, R. Borenstein et al., “The NAD-dependent deacetylase SIRT2 is required for programmed necrosis,” Nature, vol. 492, pp. 199–204, 2012. View at Google Scholar
  21. K. M. Irrinki, K. Mallilankaraman, R. J. Thapa et al., “Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis,” Molecular and Cellular Biology, vol. 31, no. 18, pp. 3745–3758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Sun, H. Wang, Z. Wang et al., “Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase,” Cell, vol. 148, no. 1-2, pp. 213–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Murphy, P. E. Czabotar, J. M. Hildebrand et al., “The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism,” Immunity, vol. 39, pp. 443–453, 2013. View at Google Scholar
  24. A. Kaczmarek, P. Vandenabeele, and D. V. Krysko, “Necroptosis: the release of damage-associated molecular patterns and its physiological relevance,” Immunity, vol. 38, pp. 209–223, 2013. View at Google Scholar
  25. M. Irmler, M. Thome, M. Hahne et al., “Inhibition of death receptor signals by cellular FLIP,” Nature, vol. 388, no. 6638, pp. 190–195, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Giampietri, S. Petrungaro, M. Musumeci et al., “c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload,” Journal of Hypertension, vol. 26, no. 5, pp. 1008–1016, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Giampietri, S. Petrungaro, P. Coluccia et al., “c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging,” Cell Death and Disease, vol. 1, no. 4, article e38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Giampietri, S. Petrungaro, F. Padula et al., “Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent,” Apoptosis, vol. 17, no. 11, pp. 1210–1222, 2012. View at Google Scholar
  29. C. Giampietri, S. Petrungaro, A. Facchiano, A. Filippini, and E. Ziparo, “Therapeutic implications of autophagy modulation in prostate cancer,” Journal of Endocrinological Investigation, vol. 35, no. 10, p. 945, 2012. View at Google Scholar
  30. C. Quintavalle, M. Incoronato, L. Puca et al., “C-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3Β activity,” Cell Death and Differentiation, vol. 17, no. 12, pp. 1908–1916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. E. E. Varfolomeev, M. Schuchmann, V. Luria et al., “Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally,” Immunity, vol. 9, no. 2, pp. 267–276, 1998. View at Google Scholar · View at Scopus
  32. W.-C. Yeh, J. L. de la Pompa, M. E. McCurrach et al., “FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis,” Science, vol. 279, no. 5358, pp. 1954–1958, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. W.-C. Yeh, A. Itie, A. J. Elia et al., “Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development,” Immunity, vol. 12, no. 6, pp. 633–642, 2000. View at Google Scholar · View at Scopus
  34. C. Dillon, A. Oberst, R. Weinlich et al., “Survival function of the FADD-CASPASE-8-cFLIPL complex,” Cell Reports, vol. 1, pp. 401–407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Tenev, K. Bianchi, M. Darding et al., “The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs,” Molecular Cell, vol. 43, no. 3, pp. 432–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Oberst, C. P. Dillon, R. Weinlich et al., “Catalytic activity of the caspase-8-FLIP L complex inhibits RIPK3-dependent necrosis,” Nature, vol. 471, no. 7338, pp. 363–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Vanlangenakker, T. Vanden Berghe, and P. Vandenabeele, “Many stimuli pull the necrotic trigger, an overview,” Cell Death and Differentiation, vol. 19, no. 1, pp. 75–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. M. Srinivasula and J. D. Ashwell, “IAPs: what's in a name?” Molecular Cell, vol. 30, no. 2, pp. 123–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, F. Du, and X. Wang, “TNF-alpha induces two distinct caspase-8 activation pathways,” Cell, vol. 133, no. 4, pp. 693–703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. W. He, Q. Wang, B. Srinivasan et al., “A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy,” Oncogene, 2013. View at Publisher · View at Google Scholar
  41. M. Feoktistova, P. Geserick, B. Kellert et al., “CIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms,” Molecular Cell, vol. 43, no. 3, pp. 449–463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. I. Roach and N. M. P. Clarke, “Physiological cell death of chondrocytes in vivo is not confined to apoptosis: new observations on the mammalian growth plate,” Journal of Bone and Joint Surgery B, vol. 82, no. 4, pp. 601–613, 2000. View at Google Scholar · View at Scopus
  43. M. Chautan, G. Chazal, F. Cecconi, P. Gruss, and P. Golstein, “Interdigital cell death can occur through a necrotic and caspase-independent pathway,” Current Biology, vol. 9, no. 17, pp. 967–970, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. M. C. Bonnet, D. Preukschat, P.-S. Welz et al., “The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation,” Immunity, vol. 35, no. 4, pp. 572–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Golstein and G. Kroemer, “Redundant cell death mechanisms as relics and backups,” Cell Death and Differentiation, vol. 12, supplement 2, pp. 1490–1496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. N. S. Wilson, V. Dixit, and A. Ashkenazi, “Death receptor signal transducers: nodes of coordination in immune signaling networks,” Nature Immunology, vol. 10, no. 4, pp. 348–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. T.-B. Kang, T. Ben-Moshe, E. E. Varfolomeev et al., “Caspase-8 serves both apoptotic and nonapoptotic roles,” Journal of Immunology, vol. 173, no. 5, pp. 2976–2984, 2004. View at Google Scholar · View at Scopus
  48. L. Salmena, B. Lemmers, A. Hakem et al., “Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity,” Genes and Development, vol. 17, no. 7, pp. 883–895, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. I. L. Ch'en, J. S. Tsau, J. D. Molkentin, M. Komatsu, and S. M. Hedrick, “Mechanisms of necroptosis in T cells,” The Journal of Experimental Medicine, vol. 208, no. 4, pp. 633–641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Degterev, J. Hitomi, M. Germscheid et al., “Identification of RIP1 kinase as a specific cellular target of necrostatins,” Nature Chemical Biology, vol. 4, no. 5, pp. 313–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. W. J. Kaiser, J. W. Upton, A. B. Long et al., “RIP3 mediates the embryonic lethality of caspase-8-deficient mice,” Nature, vol. 471, no. 7338, pp. 368–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Z. Imtiyaz, S. Rosenberg, Y. Zhang et al., “The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells,” Journal of Immunology, vol. 176, no. 11, pp. 6852–6861, 2006. View at Google Scholar · View at Scopus
  53. S. L. Osborn, G. Diehl, S.-J. Han et al., “Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 29, pp. 13034–13039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Zhang, S. Rosenberg, H. Wang, H. Z. Imtiyaz, Y.-J. Hou, and J. Zhang, “Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis,” Journal of Immunology, vol. 175, no. 5, pp. 3033–3044, 2005. View at Google Scholar · View at Scopus
  55. H. Zhang, X. Zhou, T. McQuade, J. Li, F. K. Chan, and J. Zhang, “Functional complementation between FADD and RIP1 in embryos and lymphocytes,” Nature, vol. 471, pp. 373–376, 2011. View at Google Scholar
  56. J. Zhang, D. Cado, A. Chen, N. H. Kabra, and A. Winoto, “Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1,” Nature, vol. 392, no. 6673, pp. 296–300, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Bohgaki, J. Mozo, L. Salmena et al., “Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice,” Journal of Cell Biology, vol. 195, no. 2, pp. 277–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Strasser, “The role of BH3-only proteins in the immune system,” Nature Reviews Immunology, vol. 5, no. 3, pp. 189–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Bouillet, D. Metcalf, and D. C. S. Huang, “Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity,” Science, vol. 286, no. 5445, pp. 1735–1738, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. J. W. Upton, W. J. Kaiser, and E. S. Mocarski, “Virus inhibition of RIP3-dependent necrosis,” Cell Host and Microbe, vol. 7, no. 4, pp. 302–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Trichonas, A. Manola, Y. Morizane et al., “A novel nonradioactive method to evaluate vascular barrier breakdown and leakage,” Investigative Ophthalmology and Visual Science, vol. 51, no. 3, pp. 1677–1682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. C. T. Smith, S. M. Davidson, S. Y. Lim, J. C. Simpkin, J. S. Hothersall, and D. M. Yellon, “Necrostatin: a potentially novel cardioprotective agent?” Cardiovascular Drugs and Therapy, vol. 21, no. 4, pp. 227–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. François, V. Le Cabec, M.-A. Dupont, P. J. Sansonetti, and I. Maridonneau-Parini, “Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization,” Infection and Immunity, vol. 68, no. 3, pp. 1289–1296, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. J. F. Koterski, M. Nahvi, M. M. Venkatesan, and B. Haimovich, “Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages,” Infection and Immunity, vol. 73, no. 1, pp. 504–513, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Ma, V. Temkin, H. Liu, and R. M. Pope, “NF-κB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein,” The Journal of Biological Chemistry, vol. 280, no. 51, pp. 41827–41834, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Bamias, L. G. Jia, and F. Cominelli, “The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation,” Current Opinion in Gastroenterology, vol. 29, pp. 597–602, 2013. View at Google Scholar
  67. P.-S. Welz, A. Wullaert, K. Vlantis et al., “FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation,” Nature, vol. 477, no. 7364, pp. 330–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Liu, B. Xu, W. Shen et al., “Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1,” Leukemia, vol. 26, pp. 1293–1300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. J. P. Alameda, R. Moreno-Maldonado, M. Navarro et al., “An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells,” Oncogene, vol. 29, no. 50, pp. 6522–6532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Han, L. Li, S. Qiu et al., “Shikonin circumvents cancer drug resistance by induction of a necroptotic death,” Molecular Cancer Therapeutics, vol. 6, no. 5, pp. 1641–1649, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Wu, Z. Jiang, H. Duan et al., “Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells,” Biomedicine & Pharmacotherapy, vol. 67, pp. 701–706, 2013. View at Google Scholar